On Friday, Opko Health Inc (NASDAQ: OPK) opened at On Friday, remained unchanged from the last session, before settling in for the closing price of $1.36. Price fluctuations for OPK have ranged from $1.19 to $2.04 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -4.59%. Company’s average yearly earnings per share was noted -326.79% at the time writing. With a float of $350.22 million, this company’s outstanding shares have now reached $671.61 million.
Considering the fact that the conglomerate employs 2997 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 32.12%, operating margin of -21.43%, and the pretax margin is -0.08%.
Opko Health Inc (OPK) Insider Activity
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Opko Health Inc is 55.84%, while institutional ownership is 32.06%. The most recent insider transaction that took place on Apr 10 ’25, was worth 169,712. In this transaction CEO & Chairman of this company bought 125,000 shares at a rate of $1.36, taking the stock ownership to the 214,001,448 shares. Before that another transaction happened on Apr 08 ’25, when Company’s CEO & Chairman bought 125,000 for $1.48, making the entire transaction worth $184,650. This insider now owns 213,876,448 shares in total.
Opko Health Inc (OPK) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -326.79% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -11.20% during the next five years compared to 32.04% growth over the previous five years of trading.
Opko Health Inc (NASDAQ: OPK) Trading Performance Indicators
Check out the current performance indicators for Opko Health Inc (OPK). In the past quarter, the stock posted a quick ratio of 2.28. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.56.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.08, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.20 in one year’s time.
Technical Analysis of Opko Health Inc (OPK)
Compared to the last year’s volume of 4.28 million, its volume of 2.81 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 73.06%. Additionally, its Average True Range was 0.06.
During the past 100 days, Opko Health Inc’s (OPK) raw stochastic average was set at 18.18%, which indicates a significant decrease from 81.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.61% in the past 14 days, which was lower than the 43.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4448, while its 200-day Moving Average is $1.5416. Nevertheless, the first resistance level for the watch stands at $1.3867 in the near term. At $1.4133, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.4367. If the price goes on to break the first support level at $1.3367, it is likely to go to the next support level at $1.3133. Should the price break the second support level, the third support level stands at $1.2867.
Opko Health Inc (NASDAQ: OPK) Key Stats
There are currently 793,053K shares outstanding in the company with a market cap of 1.08 billion. Presently, the company’s annual sales total 713,140 K according to its annual income of -53,220 K. Last quarter, the company’s sales amounted to 149,950 K and its income totaled -67,610 K.
